|
|||
2014-03-03 12:10:00 CET 2014-03-03 12:10:47 CET REGLAMENTUOJAMA INFORMACIJA Orion - Annual Financial ReportOrion Group Financial Statement documents 2013 and Corporate Governance Statement publishedORION CORPORATION STOCK EXCHANGE RELEASE 3 MARCH 2014 at 1.10 p.m. EET Orion Group Financial Statement documents 2013 and Corporate Governance Statement published Orion Group's Financial Statement documents for 2013 have been published. The documents are available in Finnish and English on the Company's website at http://www.orion.fi. The official financial statement documents, which include the financial statements, the report of the Board of Directors and the auditor's report are available in Finnish at http://www.orion.fi/Orion/Yhtiokokoukset/Yhtiokokous- 2014/. Orion's Corporate Governance Statement for year 2013, adopted by the Board of Directors, is published as a separate report in Finnish and English on the Company's website at http://www.orion.fi/. Orion Corporation Olli Huotari Terhi Ormio SVP, Corporate Functions VP, Communications Publisher: Orion Corporation Communications Orionintie 1A, FI-02200 Espoo, Finland Homepage: www.orion.fi Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler® pulmonary drugs. Orion's net sales in 2013 amounted to EUR 1,007 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki. [HUG#1765821] |
|||
|